Exploring NICU nurses' views of a novel genetic point‐of‐care test identifying neonates at risk of antibiotic‐induced ototoxicity: A qualitative study

Author:

Brown Georgia12ORCID,Warrington Natalie12,Ulph Fiona3,Booth Nicola4,Harvey Karen5,James Rachel12,Tricker Karen1,Wilson Paul6,Newman William12,Mcdermott John Henry12,Stoddard Duncan7,Mahaveer Ajit4,Turner Mark5,Corry Rachel1,Garlick Julia1,Miele Gino8,Ainsworth Shaun8,Kemp Laura8,Bruce Iain910,Body Richard1112,Roberts Peter13,Macleod Rhona12

Affiliation:

1. Manchester Centre for Genomic Medicine, St Mary's Hospital Manchester University NHS Foundation Trust Manchester UK

2. Division of Evolution and Genomic Sciences, School of Biological Sciences University of Manchester Manchester UK

3. Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health University of Manchester, Manchester Academic Health Science Centre Manchester UK

4. Newborn Intensive Care Unit Manchester University NHS Foundation Trust Manchester UK

5. Newborn Intensive Care Unit Liverpool Women's Hospital Liverpool UK

6. Alliance Manchester Business School University of Manchester Manchester UK

7. DS Analytics and Machine Learning Ltd London UK

8. Genedrive Diagnostics Ltd Manchester UK

9. Hearing Health Theme Manchester NIHR Biomedical Research Centre Manchester UK

10. Paediatric ENT Department, Royal Manchester Children's Hospital Manchester University NHS Foundation Trust Manchester UK

11. Emergency Department Manchester University NHS Foundation Trust Manchester UK

12. Division of Cardiovascular Sciences University of Manchester Manchester UK

13. Market Access and Reimbursement Solutions Ltd Liverpool, Merseyside UK

Abstract

AbstractAimTo explore the views of neonatal intensive care nursing staff on the deliverability of a novel genetic point‐of‐care test detecting a genetic variant associated with antibiotic‐induced ototoxicity.DesignAn interpretive, descriptive, qualitative interview study.MethodsData were collected using semi‐structured interviews undertaken between January and November 2020. Participants were neonatal intensive care nursing staff taking part in the Pharmacogenetics to Avoid Loss of Hearing trial.ResultsThematic analysis resulted in four themes: perceived clinical utility; the golden hour; point‐of‐care device; training and support. Recommendations were made to streamline the protocol and ongoing training and support were considered key to incorporating the test into routine care.ConclusionExploring the views of nurses involved in the delivery of the point‐of‐care test was essential in its implementation. By the study endpoint, all participants could see the value of routine clinical introduction of the point‐of care test.Implications for the Profession and/or Patient CareNurses are in a key position to support the delivery of point‐of‐care genetic testing into mainstream settings. This study has implications for the successful integration of other genetic point‐of‐care tests in acute healthcare settings.ImpactThe study will help to tailor the training and support required for routine deployment of the genetic point‐of‐care test. The study has relevance for nurses involved in the development and delivery of genetic point‐of‐care tests in other acute hospital settings.Reporting MethodThis qualitative study adheres to the Standards for Reporting Qualitative Research EQUATOR guidelines and utilizes COREQ and SRQR checklists.Patient or Public ContributionAll staff working on the participating neonatal intensive care units were trained to use the genetic point‐of‐care test. All inpatients on the participating units were eligible to have testing via the point‐of‐care test. The Pharmacogenetics to Avoid Loss of Hearing Patient and Public Involvement and Engagement group provided valuable feedback.Trial and Protocol RegistrationRegistered within the University of Manchester. Ethics approval reference numbers: IRAS: 253102 REC reference: 19/NW/0400. Also registered with the ISRCTN ref: ISRCTN13704894.

Publisher

Wiley

Reference33 articles.

1. Prevalence of Mitochondrial 1555A→G Mutation in European Children

2. Interactive Management Challenges With Point-of-Care Testing

3. Primary care providers' experiences with and perceptions of personalized genomic medicine;Carroll J. C.;Canadian Family Physician,2016

4. Implementation of pharmacogenomics into inpatient general medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3